Background: Obesity complicates medical, nursing, and informal care in severe illness, but its effect on hospice use and Medicare expenditures is unknown.
S
eventy percent of U.S. adults aged 60 years or older are overweight or obese (1) . Obesity is associated with shorter life expectancy, increased risk for hospitalization, and higher use of intensive care services (2-4), as well as variation in the quality of cancer screening, immunization, cancer care, and intensive care (4 -8) .
For obese persons, technical and logistical issues arise during hospitalizations, surgery, and end-of-life care that require special attention. Obesity challenges the ability of health care providers and caregivers to conduct thorough physical assessments, assist with mobility and self-care, recognize frailty and malnutrition, and perform certain indicated procedures (8 -11) . In addition, weight stigma has been found to modify patients' and providers' behaviors, potentially resulting in delayed diagnoses, suboptimal care, and weaker therapeutic alliances (12) (13) (14) (15) . To date, however, no studies have examined the association between obesity and hospice use, a cornerstone of end-of-life care.
To understand the effect of body mass index (BMI) on hospice use and Medicare expenditures at the end of life, we used the HRS (Health and Retirement Study) to examine hospice enrollment, days enrolled in hospice, decedents' place of death, and Medicare expenditures as a function of participant BMI, controlling for demographic, medical, functional, and geographic factors. In the context of the unique challenges to care for obese persons, we hypothesized that higher BMI would be associated with decreased hospice use and fewer in-home deaths due to patient, provider, and system factors affecting referral to and enrollment in hospice services, and that higher BMI would be associated with increased health care expenditures due to increased use of hospital and health care services.
were more likely to die unexpectedly, we used the exit interview question, "Was the death expected at about the time it occurred or was it unexpected?" Response options included "yes," "unsure," or "no"; the latter 2 (n = 14) were grouped as negative responses. The time between response to the last survey and death was calculated using the date of survey administration and the date of death from National Death Index data.
Statistical Analysis
We modeled hospice enrollment, days enrolled in hospice, in-home death, and Medicare expenditures using generalized linear models. The models used a binomial distribution and logit link for hospice enrollment and in-home death, a Poisson distribution and log link for total hospice days, and a gamma distribution and log link for expenditures. We examined possible models for the functional form of BMI included as a categorical variable (using National Institutes of Health obesity categories), a linear functional form, and a quadratic functional form based on theory and empirical evidence (see the Appendix, available at Annals.org) (22) . We report findings from our final models using BMI fit as a quadratic functional form based on theory, previous evidence about how BMI should vary with each outcome, and comparisons of overall model fit as well as discrimination and calibration testing. Models controlled for age at death, sex, nonwhite race, Hispanic ethnicity, marital status, total household assets, comorbid illnesses (19) , limitations in ADLs and IADLs, cognitive function, quintile of regional end-of-life expenditures, and year of death.
In sensitivity analyses, to explore the extent to which the association of BMI and the outcomes was influenced by the length of time between the collection of BMI information and death, the aforementioned model was changed to include an interaction term between BMI and the time from collection of self-reported height and weight to death (23) . To explore the extent to which the association of BMI and the outcomes was influenced by cause of death and proxy-reported expected death, each of these terms was added separately to the model. We also fit models with BMI defined as a categorical variable. In addition, we repeated the analysis with the complete HRS cohort of deceased fee-for-service beneficiaries (including nursing home residents) to see whether selecting communitydwelling respondents biased the overall results.
We report each measure in terms of the mean predicted outcome (probability of hospice enrollment, days enrolled in hospice, probability of in-home death, and Medicare expenditures) at 5 BMI levels (20, 25, 30, 35 , and 40 kg/m 2 ) and significance testing using 95% CIs. The mean predicted outcome was estimated by the statistical model for a given BMI while holding all other covariates at known values (24). Probabilities were reported as the percentage chance of the outcome occurring (0% to 100%). If the 95% CI did not contain the null hypothesis value, the results were considered statistically significant. We used Stata, version ORIGINAL RESEARCH Obesity, Hospice Use, and Medicare Expenditures 14.0 (StataCorp), for all analyses, specifically the glm and margins commands.
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RESULTS
Of 9859 HRS decedents who consented to linkage of survey data with Medicare claims data, 2485 with any managed care enrollment during the last 6 months of life were excluded. We also excluded 1352 decedents who reported living in a nursing facility at the last survey wave and participants with missing information from the last survey on date of the survey (n = 88), height or weight (n = 93), ZIP code (n = 23), marital status (n = 3), ADLs (n = 41), or cognitive function (n = 97) (Appendix Figure, available The overall observed incidence of hospice enrollment was 34.7%. Participants with higher BMI had a significantly lower likelihood of hospice enrollment than those with a BMI of 20 kg/m 2 ( Figure) . Participants with a BMI of 40 kg/m 2 had a predicted probability of hospice enrollment of 23.1% (95% CI, 19.5% to 26.7%), whereas those with a BMI of 20 kg/m 2 had a predicted probability of 38.3% (CI, 36.5% to 40.2%) ( Table 2) . Among those who enrolled in hospice care, the predicted total hospice days decreased as BMI increased. Participants with a BMI of 40 kg/m 2 spent 4.3 fewer days (CI, Ϫ5.7 to Ϫ2.9 days) in hospice care than those with a BMI of 20 kg/m 2 . This effect was driven by decreased numbers of days spent in home hospice care, and we found no clinically significant increase in facility hospice care for obese patients (Appendix Table 2 , available at Annals.org).
The overall observed incidence of in-home death was 59.6%. Participants with higher BMI had a significantly lower likelihood of in-home death than those with a BMI of 20 kg/m 2 ( Figure) . Participants with a BMI of 40 kg/m 2 had a predicted probability of in-home death of 55.0% (CI, 51.0% to 58.9%), whereas those Results are adjusted for decedent age, race/ethnicity, marital status, 28 Elixhauser medical conditions, total household assets, number of activities of daily living, number of instrumental activities of daily living, cognitive function (normal, mild cognitive impairment/cognitive impairment, no dementia, or dementia), quintile of regional end-of-life expenditures, and year of death. Shaded areas represent 95% CIs. BMI = body mass index.
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Obesity, Hospice Use, and Medicare Expenditures with a BMI of 20 kg/m 2 had a predicted probability of 61.3% (CI, 59.4% to 63.2%) ( Table 2) .
In the last 6 months of life, total predicted Medicare expenditures increased as BMI increased. The mean total predicted expenditures were $42 803 (CI, $41 085 to $44 521) ( Table 2) Table 3) .
To examine whether this analysis was confounded by cause of death or proxy-reported expected death, we refit the model with these variables included. Diabetes-and renal-related causes of death were more common for obese and morbidly obese respondents than for those with normal BMI (18.5 to 24.9 kg/m 2 ) (Appendix Table 3 , available at Annals.org). When we included the decedent's cause of death as a covariate, we observed trends and effect sizes that were consistent with the results from the original model (Appendix Table 4 , available at Annals.org). The likelihood that a proxy reported the death as "expected" decreased as BMI increased: 55% of deaths were expected by proxies for normal-weight participants compared with 45% for morbidly obese participants (Appendix Table 3 ). When we included expected death as a model covariate, the effect sizes also remained stable (Appendix Table 4). When we included an interaction term between BMI and time from survey data collection, the trends and effect sizes of the outcomes were similar (Appendix Table 4 ).
The main outcomes are reported by BMI categories in Appendix Tables 5 and 6 (available at Annals .org), and the trends and effect sizes of the outcomes were similar to when BMI was modeled as a continuous variable. The main outcomes with nursing home residents included were similar to those in the communitydwelling cohort and are presented in Appendix 
DISCUSSION
In this large national sample of older American decedents, we found that increased BMI was independently associated with decreased hospice enrollment, duration of hospice services, and in-home death and increased Medicare expenditures in the last 6 months of life, after adjustment for key sociodemographic, medical, functional status, and geographic factors. In- Obesity, Hospice Use, and Medicare Expenditures ORIGINAL RESEARCH creasing BMI was associated with higher expenditures for inpatient, outpatient, and physician claims, although these were partially offset by lower hospice, durable medical equipment, and skilled-nursing expenditures in this community-dwelling population. Obesity was a risk factor for lower-quality end-of-life care, which we defined as enrollment in hospice, longer length of hospice stay, and in-home death. Additional research should focus on the mechanisms underlying this vulnerability at the end of life.
In this study, we showed that higher BMI was a strong negative predictor of hospice enrollment; the predicted probability of hospice enrollment was 40% lower for decedents with a BMI of 40 kg/m 2 than for those with a BMI of 20 kg/m 2 . Hospice enrollment has previously been shown to vary by sex, race, ethnicity, primary diagnosis, location before enrollment, referring physician, patient preferences with regard to lifesustaining treatment, and site of death (25) (26) (27) (28) (29) (30) , but this is, to our knowledge, the first study to identify obesity as an independent risk factor for disparity in the use of hospice services. Previous studies have shown that hospice use is associated with improved quality of care for patients and their families, with reduced psychiatric morbidity and increased ratings of perceived health care quality in bereaved caregivers (31-36), heightening concerns about the effect of underuse of hospice care in this population (33, 37, 38).
We hypothesize that obesity may affect hospice enrollment through 2 mechanisms: referral behaviors and enrollment policies. First, prolonged cachexia experienced by some persons at the end of life is recognized by family members and physicians as being closely related to the dying process (39). Those who do not experience profound cachexia may be less likely to be recognized as appropriate referrals for palliative or hospice services by providers compared with more cachectic persons, who may appear less physically robust. The trajectories of illness and dying may vary as a function of patient obesity within diseases. Obese patients may have a more sudden decline in performance status or increase in metabolic abnormalities, which may lead to more sudden deaths than in nonobese patients. In this study, the effect of obesity was not substantially moderated by whether the death was expected or the cause of death was known. However, little research is available on the association between trajectories of illness and obesity, and this may be an important factor in the provision of high-quality end-oflife health care.
Second, enrollment policies vary among hospice services, and some restrict access to care for persons with higher-cost medical needs (27) . Obese patients in home hospice care may require increased nursing assistance, including mechanical lift devices to provide proper positioning and personal care in the terminal Obesity is associated with increased use of health care services and associated expenditures (41-44). For obese participants in this community-dwelling cohort, we found that inpatient, outpatient, and physician Medicare expenditures were 13% higher (a difference of $4343), but hospice, home health, and durable medical equipment expenditures were 20% lower (a difference of $1173). Increased expenditures for obese persons have been attributed to the relatively increased prevalence of medical conditions, such as diabetes, hypertension, and coronary artery disease (45-47). However, higher BMI presents many challenges to medical management beyond increased medical multimorbidity. It is associated with decreased access to medical care, increased difficulty managing medical issues in an outpatient setting versus an inpatient setting, and more challenges in transitioning from inpatient care back to home care (48 -52). Finally, there is an established record of negative provider attitudes and implicit bias against obese persons, and these attitudes may continue to influence care for obese persons at the end of life (13, 14) . Each of these factors may impede the provision of optimal medical, nursing, and supportive care for obese persons, either independently or together, thus explaining the independent effect of obesity on end-of-life health care expenditures.
Our study has several potential limitations. We used a self-reported BMI measure that was collected a median of 16 months before death, and the time from collection of this biometric to death varied within the study cohort. A sensitivity analysis examining whether this interval affected the association between BMI and the outcomes showed that this was not substantial and did not change the overall effect. We examined only community-dwelling adults using fee-for-service Medicare claims, but our results did not differ significantly when nursing home residents were included in the sample. The sample did not include respondents who were enrolled in managed care Medicare plans; this group may have substantially different characteristics and resource use at the end of life, which may limit the generalizability of these results (53). Although we controlled for the presence of more than 2 dozen medical conditions, functional status (limitations in ADLs and IADLs and cognitive function) at the last core survey interview, cause of death, and the proxy informant's judgment of whether the death was expected, residual confounding may have inadequately controlled for differences in medical conditions and trajectories of illness that are affected by obesity.
These potential limitations notwithstanding, this study identified a significant relationship in decedents between obesity and decreased probability of hospice enrollment and in-home death, as well as fewer days of hospice care among those who were enrolled. The consequences of obesity for health care use and expenditures are substantial, and obese persons are vulnerable to suboptimal end-of-life care. As stakeholders look for opportunities to improve the value of care by increasing quality and decreasing low-value services, the disparities in hospice use and Medicare expenditures by patient BMI provide an excellent opportunity for improvement. Policy interventions could include increased reimbursement for home care services of obese patients who require multiple support personnel, reimbursement for patient lifts and other special durable medical equipment in health care facilities, or concurrent palliative care for select patients with severe obesity. All people-regardless of body size-and their families should have equal opportunities to experience the benefits of high-quality end-of-life health care. 
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APPENDIX: STATISTICAL MODEL SELECTION AND COMPOSITION
The statistical model development process began with a conceptual model of how obesity may affect end-of-life decision making. On the basis of the conceptual model, we selected from among the many variables available in the HRS to make an inclusive yet parsimonious selection of variables to include as confounders.
On the basis of the distributions of the dependent variables, we used 3 separate statistical models to properly describe dependent variables that were dichotomous (hospice enrollment and in-home death), continuous count data (number of days in hospice), and continuous and skewed data (total Medicare expenditures). On the basis of the known distributions, we chose generalized linear models with various response probability distributions and link functions: a binomial distribution and logit link for hospice enrollment and in-home death, a Poisson distribution and log link for total hospice days, and a gamma distribution and log link for expenditures.
The primary independent variable was BMI. In choosing the functional form that BMI would take in the models, we first examined previous literature about how BMI affects health care outcomes. Although there are few data about health care use (most models treat it as a categorical variable), published literature about BMI and mortality described a nonlinear function form, second-order or higher (22, 54, 55) .
Next, on the basis of our hypothesized relationship between the outcomes and BMI, we believed that BMI would approximate a functional quadratic form. Specifically, we believed that as BMI increased, there would be increasing challenges of prognostication for providers and perhaps family, as well as challenges in the use of home-based care or provision of hospice services. We did not expect these challenges to increase in a linear manner as BMI increased; rather, we expected the effect to be relatively constant for more severe BMI values.
We used the traditional World Health Organization BMI categories as the basis of our model, as part of a modified splines analysis, to examine the functional form of the outcomes in relation to BMI in a nonparametric form. As we noted in our sensitivity analysis using World Health Organization/National Institutes of Health BMI categories (Appendix Tables 5 and 6), this functional form is roughly quadratic, with an increasing relationship that levels off at the more severe BMI categories. We also explored the functional form of BMI as a cubic term to determine whether there was any advantage in terms of model fit when using higher-order forms of BMI.
To help choose the most appropriate functional form of BMI (categorical, linear, quadratic, or cubic), we examined the overall model fit, the calibration across deciles of predicted probabilities to ensure that the model had randomly distributed residuals (observed vs. predicted values), and its discrimination across the range of BMI values.
On the basis of this analysis, we used a quadratic functional form for our primary independent variable in the final models. We reported the mean predicted probability of the outcomes for the study sample when BMI was held at 5 levels (20, 25, 30, 35 , or 40 kg/m 2 ) and the rest of the variables were held at known values. We used the same quadratic functional form for BMI, regardless of the outcome, to allow the model to be as simple and understandable to readers as possible.
Our analysis also included 4 variations on the aforementioned statistical model and covariates. First, we examined the association of BMI and the predicted outcomes if an interaction term between the quadratic BMI term and the interval between the last survey and death was added to the full model. Second, we examined the association between BMI and the predicted outcomes if a covariate measuring cause of death was added to the full model. Third, we examined the association between BMI and the predicted outcomes if a covariate quantifying whether the survey proxy reported the decedent's death as "expected" was added to the full model. Finally, we included all available HRS decedents (including those who reported being in a nursing home at the last survey before death) to examine whether exclusion of these respondents led to substantial selection bias in the study sample. Original model with addition of interaction term between BMI and time from survey to death (n ‫؍‬ 5677) Predicted probability of hospice enrollment, % 28 Elixhauser medical conditions, total household assets, limitations in activities of daily living and instrumental activities of daily living, cognitive function, quintile of regional end-of-life expenditures, and year of death. This cohort includes 5677 community-dwelling decedents and 1298 nursing home-dwelling decedents. These totals exclude 345 community-dwelling decedents and 54 nursing home-dwelling decedents who were excluded from the study cohort because of missing covariate data. Values are means (95% CIs). † Among decedents who were ever enrolled in hospice (n = 2412). 
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